Annual EBIT
-$77.51 M
-$4.86 M-6.69%
31 December 2021
Summary:
Concert Pharmaceuticals annual earnings before interest & taxes is currently -$77.51 million, with the most recent change of -$4.86 million (-6.69%) on 31 December 2021. During the last 3 years, it has fallen by -$4.86 million (-6.69%).CNCE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$29.61 M
-$3.92 M-15.27%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly earnings before interest & taxes is currently -$29.61 million, with the most recent change of -$3.92 million (-15.27%) on 30 September 2022.CNCE Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$124.27 M
-$2.81 M-2.31%
30 September 2022
Summary:
Concert Pharmaceuticals TTM earnings before interest & taxes is currently -$124.27 million, with the most recent change of -$2.81 million (-2.31%) on 30 September 2022.CNCE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -6.7% | -10.5% | -88.1% |
| 5 y5 years | -39.4% | -62.3% | -59.1% |
CNCE EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -179.8% | -122.6% | -217.6% |
Concert Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$29.61 M(+15.3%) | -$124.27 M(+2.3%) |
| June 2022 | - | -$25.68 M(-28.7%) | -$121.46 M(+35.6%) |
| Mar 2022 | - | -$36.03 M(+9.3%) | -$89.56 M(+15.5%) |
| Dec 2021 | -$77.51 M(+6.7%) | -$32.95 M(+23.0%) | -$77.51 M(+17.3%) |
| Sept 2021 | - | -$26.80 M(-530.9%) | -$66.06 M(+12.7%) |
| June 2021 | - | $6.22 M(-125.9%) | -$58.63 M(-24.8%) |
| Mar 2021 | - | -$23.98 M(+11.5%) | -$77.98 M(+7.3%) |
| Dec 2020 | -$72.65 M(-8.1%) | -$21.50 M(+11.1%) | -$72.65 M(+0.8%) |
| Sept 2020 | - | -$19.36 M(+47.4%) | -$72.10 M(+1.6%) |
| June 2020 | - | -$13.13 M(-29.6%) | -$70.98 M(-8.1%) |
| Mar 2020 | - | -$18.65 M(-11.0%) | -$77.27 M(-2.2%) |
| Dec 2019 | -$79.02 M(+42.2%) | -$20.95 M(+14.9%) | -$79.02 M(+1.1%) |
| Sept 2019 | - | -$18.24 M(-6.1%) | -$78.13 M(+1.2%) |
| June 2019 | - | -$19.43 M(-4.8%) | -$77.22 M(+7.0%) |
| Mar 2019 | - | -$20.39 M(+1.6%) | -$72.17 M(+29.8%) |
| Dec 2018 | -$55.58 M(-157.8%) | -$20.06 M(+15.7%) | -$55.58 M(+26.1%) |
| Sept 2018 | - | -$17.34 M(+20.6%) | -$44.06 M(-142.3%) |
| June 2018 | - | -$14.37 M(+277.6%) | $104.13 M(-1.5%) |
| Mar 2018 | - | -$3.81 M(-55.4%) | $105.68 M(+10.1%) |
| Dec 2017 | $96.15 M | -$8.54 M(-106.5%) | $96.02 M(+3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $130.85 M(-1120.5%) | $92.52 M(-286.2%) |
| June 2017 | - | -$12.82 M(-4.8%) | -$49.69 M(-1.2%) |
| Mar 2017 | - | -$13.47 M(+11.8%) | -$50.31 M(-1.0%) |
| Dec 2016 | -$50.72 M(-303.6%) | -$12.04 M(+6.0%) | -$50.81 M(+33.5%) |
| Sept 2016 | - | -$11.36 M(-15.5%) | -$38.06 M(+7.6%) |
| June 2016 | - | -$13.44 M(-3.8%) | -$35.37 M(-278.7%) |
| Mar 2016 | - | -$13.97 M(-2076.5%) | $19.79 M(-20.6%) |
| Dec 2015 | $24.91 M(-181.5%) | $707.00 K(-108.2%) | $24.91 M(+61.0%) |
| Sept 2015 | - | -$8.66 M(-120.8%) | $15.47 M(-6.4%) |
| June 2015 | - | $41.72 M(-571.2%) | $16.54 M(-150.3%) |
| Mar 2015 | - | -$8.85 M(+1.4%) | -$32.89 M(+7.7%) |
| Dec 2014 | -$30.55 M(+596.0%) | -$8.73 M(+15.0%) | -$30.55 M(+11.5%) |
| Sept 2014 | - | -$7.59 M(-1.5%) | -$27.39 M(+1.8%) |
| June 2014 | - | -$7.71 M(+18.3%) | -$26.91 M(+175.0%) |
| Mar 2014 | - | -$6.51 M(+16.9%) | -$9.79 M(+122.9%) |
| Dec 2013 | -$4.39 M(-76.4%) | -$5.58 M(-21.6%) | -$4.39 M(-27.3%) |
| Sept 2013 | - | -$7.11 M(-175.5%) | -$6.04 M(-663.5%) |
| June 2013 | - | $9.42 M(-941.6%) | $1.07 M(-112.8%) |
| Mar 2013 | - | -$1.12 M(-84.5%) | -$8.35 M(+15.5%) |
| Dec 2012 | -$18.59 M(+64.5%) | -$7.23 M | -$7.23 M |
| Dec 2011 | -$11.30 M | - | - |
FAQ
- What is Concert Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of CNCE is -$77.51 M
What is the all time high annual EBIT for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual earnings before interest & taxes is $97.16 M
What is Concert Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of CNCE is -$29.61 M
What is the all time high quarterly EBIT for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly earnings before interest & taxes is $130.85 M
What is Concert Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of CNCE is -$124.27 M
What is the all time high TTM EBIT for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high TTM earnings before interest & taxes is $105.68 M